Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 6Phase 3 4Phase 2/3 2Phase 1 2

Status

Completed 55Recruiting 31Terminated 21Unknown 13Active not recruiting 9Not yet recruiting 6Withdrawn 2Suspended 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 5Thoracic 1

Conditions

Medulloblastoma 2Glioma 2Glioblastoma 2SCLC, Extensive Stage 1Recurrence 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Bevacizumab 14Injections 13Drug Therapy 10Gemcitabine 9toripalimab 8venetoclax 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Cyclophosphamide 7Carboplatin 7pembrolizumab 6irinotecan sucrosofate 6Temozolomide 6HMPL-013 6tislelizumab 5sintilimab 5fludarabine 5N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5Fluorouracil 5Etoposide 5Cisplatin 5Biopsy 5osimertinib 4lenvatinib 4Rituximab 4Radiotherapy 4Pemetrexed 4Paclitaxel 4Oxaliplatin 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Temozolomide × Clear all
NCT06639607 2026-06-03

PRiME II

Washington University School of Medicine

Phase 1/2 Not yet recruiting
68 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting
69 enrolled
CNS

Medulloblastoma

NCT07389278 2026-02-05

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

University of California, San Francisco

Phase 1/2 Not yet recruiting
97 enrolled
CNS

Glioblastoma, Glioma

NCT04373785 2025-10-21

NG101m Adjuvant Therapy in Glioblastoma Patients

NeuGATE Theranostics

Phase 1/2 Not yet recruiting
52 enrolled
CNS

Glioblastoma

NCT07141771 2025-08-26

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
100 enrolled
Thoracic

SCLC, Extensive Stage

NCT06258018 2024-08-30

ONC-2022-001

Istituto Clinico Humanitas

Phase 1/2 Not yet recruiting
86 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡